Data for andre CYP3A4- hæmmere indikerer, at midazolamkoncentrationen bliver signifikant højere, når midazolam gives oralt.
Based on data for other CYP3A4 inhibitors, plasma concentrations of midazolam are expected to be significantly higher when midazolam is given orally.